Arthritis News

WASHINGTON — Patients treated with a novel neurotrophin-3 inhibitor demonstrated significant reductions in osteoarthritis knee pain across all dosing levels, according to data presented at ACR Convergence 2024.

WASHINGTON — Lorecivivint is superior to placebo for improving pain, function and structure at 12 months and beyond in patients with knee osteoarthritis, according to data presented at ACR Convergence 2024.

DALLAS — In this video, Christopher N. Carender, MD, discussed results that showed surgeon volume may not be a modifiable risk factor for revision and periprosthetic joint infection after total knee arthroplasty in patients with obesity.

DALLAS — In this video, Joshua C. Rozell, MD, discussed outcomes of an 11-year retrospective analysis that showed several factors may increase the risk of wound complications after direct anterior total hip arthroplasty.

Obesity is more than just a number on a scale; it is a complex, chronic disease characterized by an excess of body fat that negatively impacts various aspects of health.

Published results showed navigation-assisted hip resurfacing may yield enhanced acetabular cup positioning and positive 2-year patient-reported outcomes for patients with hip osteoarthritis.

Results presented at the American Society for Surgery of the Hand Annual Meeting showed total wrist arthroplasty may supplant total wrist fusion as the gold standard treatment for older patients with OA.

The American Academy of Orthopaedic Surgeons Registry Program released its 2024 Shoulder & Elbow Registry annual report, according to a press release.

Chromosomal, hormonal and structural differences between the bodies of girls and boys may explain why osteoarthritis incidence is elevated in women vs. men later in life, according to a review published in Osteoarthritis & Cartilage.